P values less than 0.05 were considered statistically significant
Semaglutide (Ozempic, Wegovy, Rybelsus) is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management
Insight into COVID-19's epidemiology, pathology, and treatment
We wouldnt be surprised if this letter is cited in legislative testimony, legal filings, and regulatory proceedings
To verify this hypothesis, we designed a randomized controlled study to determine the effect of 4 g/day of intravenous L-carnitine administration on fatigue, hunger, body mass, lipid profile, and other CHD risk factors in MetS patients during a modified fasting period